Dr. Rajeev K. Mathavan, MD

Dr. Mathavan practices at DHR Health in Edinburg, Texas, part of DHR Health.

Dr. Mathavan's NPI, 1790705200, was assigned on July 20, 2006. Dr. Mathavan's Texas license number on file is N0953.

Dr. Mathavan's primary practice is DHR Health, at 5501 South McColl, Edinburg, TX 78539 in Hidalgo County. The practice phone is (956) 362-8677.

Dr. Mathavan's primary practice is DHR Health in Edinburg, Texas, part of DHR Health. The medical group on file is Renaissance Medical Foundation. Dmand AI also links Dr. Mathavan to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mathavan practices, 2 sites in all. Vendor and product names are available with a free account.

Geriatric medicine is Dr. Mathavan's primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Dr. Mathavan is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mathavan's licenses on file in 4 states: Texas, Connecticut, Georgia and Ohio.

Dmand AI lists acute diabetes, congestive heart failure, pneumonia and respiratory infection and sepsis among the conditions Dr. Mathavan treats.

CMS data shows 565 Medicare services from Dr. Mathavan across 4 procedure codes in 2024, for 211 Medicare patients. Medicare paid $48,962 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 211 Medicare patients who saw Dr. Mathavan in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mathavan's median patient age at 67, with 48% women.

In 2024, Dr. Mathavan wrote 194 Medicare Part D claims for 120 patients. 90% of them were for generic drugs. CMS names the drug for 57 of them, across 4 drugs with 11 or more claims each, at $496 in total drug cost. In 2023, CMS named 50 claims across 3 drugs.

Dr. Mathavan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 24 general payments to Dr. Mathavan from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $365.

Dr. Mathavan is a member of ACP and SHM.

Dr. Mathavan is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.